Nomura Research Institute, Ltd.
NRILY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $2,784,245,602 | $2,444,555,415 | $1,854,100,049 | $2,367,363,239 |
| - Cash | $168,597,000 | $173,935,000 | $129,257,000 | $115,610,000 |
| + Debt | $271,023,000 | $298,538,000 | $237,744,000 | $250,416,000 |
| Enterprise Value | $2,886,671,602 | $2,569,158,415 | $1,962,587,049 | $2,502,169,239 |
| Revenue | $764,813,000 | $736,556,000 | $692,165,000 | $611,634,000 |
| % Growth | 3.8% | 6.4% | 13.2% | – |
| Gross Profit | $275,295,000 | $261,007,000 | $239,829,000 | $216,072,000 |
| % Margin | 36% | 35.4% | 34.6% | 35.3% |
| EBITDA | $188,874,000 | $167,094,000 | $154,672,000 | $144,600,000 |
| % Margin | 24.7% | 22.7% | 22.3% | 23.6% |
| Net Income | $93,762,000 | $79,643,000 | $76,307,000 | $71,445,000 |
| % Margin | 12.3% | 10.8% | 11% | 11.7% |
| EPS Diluted | 163.56 | 136.84 | 128.88 | 120.34 |
| % Growth | 19.5% | 6.2% | 7.1% | – |
| Operating Cash Flow | $130,196,000 | $142,277,000 | $118,899,000 | $98,137,000 |
| Capital Expenditures | -$49,602,000 | -$49,797,000 | -$54,701,000 | -$42,977,000 |
| Free Cash Flow | $80,594,000 | $92,480,000 | $64,198,000 | $55,160,000 |